However, the initial choice of long-acting inhaled bronchodilator is not specified ... in preventing COPD exacerbations. In this randomized, controlled, multicenter, international trial, 7376 ...

Bronchodilator therapy forms the mainstay of treatment for people with COPD. Bronchodilators work ... of life and reduce the risk of experiencing exacerbations. It is also important to match ...

Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

Background: In contrast to asthma, the indication for bronchodilators prior to bronchoscopy in patients with COPD has not been properly investigated. We therefore performed a randomized ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Traditionally, COPD management has relied on bronchodilators ... The other big area of interest is reducing COPD exacerbation frequency. For this, we're studying targeted lung denervation ...

support the published findings of other recent COPD studies in which the beneficial and adverse effects of theophylline were analyzed in the stable phase and during exacerbation: The broad ...

The use of antibiotics in combination with oral corticosteroids to treat patients with mild-to-moderate exacerbations ... guidelines about bronchodilator use in patients with COPD and CVD are ...

Current treatment options for COPD include bronchodilators such as beta2 ... Treatment with Dupixent was shown to reduce COPD exacerbations by 30% in the BOREAS trial and by 34% in the NOTUS ...